InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Zannes Maria. Insider active across 1 company, notably bioAffinity Technologies, Inc.. Cumulatively, 8 filings have been published. Breakdown: 1 buy · 0 sell. History available since 1 January 2023. The latest transaction was disclosed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Zannes Maria is President & CEO at bioAffinity Technologies, Inc. (XNAS). There are 8 filings in total, and in the sampled recent filings the date range runs from 2022-11-22 to 2025-01-14, with buy volume of EUR 0 and sell volume of EUR 0. The main listed filings are attribution entries, including EUR 69,243.39290004935 on 2024-04-24, EUR 17,746.74244980405 on 2024-01-24, and EUR 17,594.96684700513 on 2023-07-06.